Cargando…

Erratum: Editorial: NKT Cells in Cancer Immunotherapy

Detalles Bibliográficos
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2020
Materias:	Immunology
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7489335/ https://www.ncbi.nlm.nih.gov/pubmed/32983185 http://dx.doi.org/10.3389/fimmu.2020.594504

Ejemplares similares

Editorial: NKT Cells in Cancer Immunotherapy
por: Webb, Tonya J., et al.
Publicado: (2020)

Novel Approaches to Exploiting Invariant NKT Cells in Cancer Immunotherapy
por: Wolf, Benjamin J., et al.
Publicado: (2018)

Enhancing Neuroblastoma Immunotherapies by Engaging iNKT and NK Cells
por: McNerney, Kevin O., et al.
Publicado: (2020)

α-GalCer and iNKT Cell-Based Cancer Immunotherapy: Realizing the Therapeutic Potentials
por: Zhang, Yingting, et al.
Publicado: (2019)

Promotion or Suppression of Murine Intestinal Polyp Development by iNKT Cell Directed Immunotherapy
por: Wang, Ying, et al.
Publicado: (2019)

Novel lipid antigens for NKT cells in cancer
por: Lee, Michael S., et al.
Publicado: (2023)

Vaccine Designs Utilizing Invariant NKT-Licensed Antigen-Presenting Cells Provide NKT or T Cell Help for B Cell Responses
por: Fujii, Shin-ichiro, et al.
Publicado: (2018)

Discovery of NKT cells and development of NKT cell-targeted anti-tumor immunotherapy
por: TANIGUCHI, Masaru, et al.
Publicado: (2015)

NKT Cell Networks in the Regulation of Tumor Immunity
por: Robertson, Faith C., et al.
Publicado: (2014)

NKT Cells as an Ideal Anti-Tumor Immunotherapeutic
por: Fujii, Shin-ichiro, et al.
Publicado: (2013)

Regulation of NKT Cell Localization in Homeostasis and Infection
por: Slauenwhite, Drew, et al.
Publicado: (2015)

Dynamics of NKT-Cell Responses to Chlamydial Infection
por: Shekhar, Sudhanshu, et al.
Publicado: (2015)

iNKT and MAIT Cell Alterations in Diabetes
por: Magalhaes, Isabelle, et al.
Publicado: (2015)

The Role of Autophagy in iNKT Cell Development
por: Yang, Guan, et al.
Publicado: (2018)

Editorial: NK Cell-Based Cancer Immunotherapy
por: Borrego, Francisco, et al.
Publicado: (2016)

Editorial: CD4(+) T Cells in Cancer Immunotherapies
por: González-Navajas, José M., et al.
Publicado: (2021)

Advances in NKT cell Immunotherapy for Glioblastoma
por: Pyaram, Kalyani, et al.
Publicado: (2018)

Type II NKT Cells in Inflammation, Autoimmunity, Microbial Immunity, and Cancer
por: Marrero, Idania, et al.
Publicado: (2015)

Tissue-Specific Roles of NKT Cells in Tumor Immunity
por: Terabe, Masaki, et al.
Publicado: (2018)

Editorial: Engineered immune cells in cancer immunotherapy (EICCI)
por: Martin, Francisco, et al.
Publicado: (2022)

Editorial: Translation of genetically engineered T cells in cancer immunotherapy
por: Voss, Ralf-Holger, et al.
Publicado: (2023)

CD8(+) T-cell immunity orchestrated by iNKT cells
por: Qin, Yingyu, et al.
Publicado: (2023)

Editorial: “Cancer Immunotherapy: Lights and Shadows”
por: Barrio, María Marcela, et al.
Publicado: (2015)

Editorial: Targeting Metabolism in Cancer Immunotherapy
por: Roszik, Jason, et al.
Publicado: (2018)

SOX chemotherapy with anti-PD-1 and iNKT cell immunotherapies for stage IV gastric adenocarcinoma with liver metastases: A case report
por: Li, Dezhao, et al.
Publicado: (2022)

Type II NKT Cells: An Elusive Population With Immunoregulatory Properties
por: Singh, Avadhesh Kumar, et al.
Publicado: (2018)

The Role of Adaptor Proteins in the Biology of Natural Killer T (NKT) Cells
por: Gerth, Evelyn, et al.
Publicado: (2019)

New insights into iNKT cells and their roles in liver diseases
por: Gu, Xinyu, et al.
Publicado: (2022)

Invariant NKT cells are more abundant in peanut-allergic adults and a subset of CD8(+) iNKT cells are depleted after peanut oil exposure
por: Hopkins, Georgina V., et al.
Publicado: (2023)

The Timing and Abundance of IL-2Rβ (CD122) Expression Control Thymic iNKT Cell Generation and NKT1 Subset Differentiation
por: Won, Hee Yeun, et al.
Publicado: (2021)

Editorial: Immune Checkpoint Molecules and Cancer Immunotherapy
por: Bazhin, Alexandr V., et al.
Publicado: (2018)

Editorial: Nanobody-based cancer immunotherapy and immunoimaging
por: Jafari, Mahdie, et al.
Publicado: (2023)

Editorial: Extracellular traps in cancer immunity and immunotherapy
por: Rahat, Michal A., et al.
Publicado: (2023)

Editorial: Adenosine pathways in cancer immunity and immunotherapy
por: Fu, Junjiang, et al.
Publicado: (2023)

Erratum: The efficacy of cancer immunotherapies is compromised by Helicobacter pylori infection
Publicado: (2023)

Editorial: NK cells in viral immunology and immunotherapy
por: Mulik, Sachin, et al.
Publicado: (2023)

Imaging of NKT Cell Recirculation and Tissue Migration during Antimicrobial Immunity
por: Delovitch, Terry L.
Publicado: (2015)

iNKT Cells and Their Potential Lipid Ligands during Viral Infection
por: Opasawatchai, Anunya, et al.
Publicado: (2015)

The Pathophysiological Relevance of the iNKT Cell/Mononuclear Phagocyte Crosstalk in Tissues
por: Cortesi, Filippo, et al.
Publicado: (2018)

Editorial: Immunotherapy in Multiple Myeloma
por: Giuliani, Nicola, et al.
Publicado: (2019)

Cannot write session to /tmp/vufind_sessions/sess_41905u5i7vmg8bv99t9mekkgqr